New Mountain Scraps $32 Billion Deal With Ex-Executive Holt

Core Viewpoint - New Mountain Capital has terminated a significant deal proposed by former executive Matt Holt, which aimed to acquire five portfolio companies for a total of $32 billion, marking a notable shift in the firm's strategic direction [1][2][3]. Group 1: Deal Termination - New Mountain Capital informed clients that discussions regarding the acquisition deal have ended, following multiple proposals and counteroffers [2]. - The firm cited that Holt missed a previous deadline for the offer and deemed a recent bid as less favorable than the original proposal [3]. - Concerns regarding deferred payments, debt structure, and governance issues were highlighted as reasons for the deal's termination [4]. Group 2: Financial Implications - The proposed deal would have generated over $14 billion in proceeds for New Mountain, supported by more than $12 billion in debt from major financial institutions [5]. - A revised proposal aimed at addressing concerns was also rejected, indicating ongoing challenges in reaching an agreement [6]. Group 3: Future Prospects - Holt's plan involved merging five healthcare technology companies into a new venture named Thoreau, which would leverage artificial intelligence to reduce healthcare costs [7]. - New Mountain Capital expressed belief in the potential of these companies and indicated that they may still pursue the idea of combining them without Holt's involvement [8]. - The firm is exploring various structures and exit strategies for the companies, emphasizing their commitment to maximizing value [9].